1004 related articles for article (PubMed ID: 1828637)
1. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
Ildstad ST; Wren SM; Oh E; Hronakes ML
Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
[TBL] [Abstract][Full Text] [Related]
2. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
3. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
Li H; Colson YL; Ildstad ST
Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
[TBL] [Abstract][Full Text] [Related]
4. Multiple mixed chimeras: reconstitution of lethally irradiated mice with syngeneic plus allogeneic bone marrow from multiple strains.
Chester CH; Sykes M; Sachs DH
Res Immunol; 1989; 140(5-6):503-16. PubMed ID: 2675227
[TBL] [Abstract][Full Text] [Related]
5. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn----C57BL/10Sn).
Ildstad ST; Bluestone JA; Sachs DH
J Exp Med; 1986 May; 163(5):1343-8. PubMed ID: 2939173
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
Pierce GE
Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
[TBL] [Abstract][Full Text] [Related]
7. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats.
Markus PM; Selvaggi G; Cai X; Fung JJ; Starzl TE
Cell Transplant; 1993; 2(4):345-53. PubMed ID: 8162277
[TBL] [Abstract][Full Text] [Related]
8. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
9. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance.
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Sachs DH
J Exp Med; 1985 Jul; 162(1):231-44. PubMed ID: 3159825
[TBL] [Abstract][Full Text] [Related]
11. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
12. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A+B-->A) to secondary recipients.
Wren SM; Hronakes ML; Ildstad ST
Transplantation; 1992 Dec; 54(6):1031-40. PubMed ID: 1465769
[TBL] [Abstract][Full Text] [Related]
13. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
14. Mixed chimerism to induce tolerance for solid organ transplantation.
Wren SM; Nalesnik M; Hronakes ML; Oh E; Ildstad ST
J Pediatr Surg; 1991 Apr; 26(4):439-43. PubMed ID: 2056405
[TBL] [Abstract][Full Text] [Related]
15. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
16. Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.
Xu H; Zhu Z; Huang Y; Bozulic LD; Hussain LR; Yan J; Ildstad ST
Transplantation; 2012 Mar; 93(5):469-76. PubMed ID: 22228418
[TBL] [Abstract][Full Text] [Related]
17. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.
Sharabi Y; Abraham VS; Sykes M; Sachs DH
Bone Marrow Transplant; 1992 Mar; 9(3):191-7. PubMed ID: 1387333
[TBL] [Abstract][Full Text] [Related]
18. A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers.
Koch U; Korngold R
Blood; 1997 Apr; 89(8):2880-90. PubMed ID: 9108408
[TBL] [Abstract][Full Text] [Related]
19. Induction of prolonged tolerance to third-party skin grafts following fully allogeneic bone marrow transplantation in mice.
Levite M; Reisner Y
Transplantation; 1993 Mar; 55(3):633-8. PubMed ID: 8456484
[TBL] [Abstract][Full Text] [Related]
20. Mixed xenogeneic chimeras (rat + mouse to mouse). Evidence of rat stem cell engraftment, strain-specific transplantation tolerance, and skin-specific antigens.
Ildstad ST; Boggs SS; Vecchini F; Wren SM; Hronakes ML; Johnson PC; Van den Brink MR
Transplantation; 1992 Apr; 53(4):815-22. PubMed ID: 1566347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]